Skip to content
★ Sign in to follow
HV

HCi Viocare Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Zertalis Constantinos, was filed 15 Aug 2018.

HCi Viocare: what insiders have been doing

This page follows insider dealings at HCi Viocare as filed with SEC (Form 4). HCi Viocare has had no insider filing for more than a year; the last one goes back to 15 August 2018.

Our records for HCi Viocare go back to 2014, with 40 purchases and 11 sales on the open market in total.

This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Insider Decl.
66
Thresholds
n/a
Buy Volume
€203,448
40 ops. · all time
Sell Volume
€782,591
11 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2018

FY ended December 2018 · cache

Income statement
Revenue367.9k
Gross profit239.2k65% margin
Net income-5.2M-1417.5% margin
Last declaration on 15 August 2018
Declarations66 total
  • ▲
    10% OwnerExecutives
    5,160 USD12SEC
    3,000 shares@ US$1.7211.3% of flowCommon stockSEC:0001594062-18-000153:0
    Canonical exit: 18 Oct 2018 (T+90)
  • ▲
    10% OwnerExecutives
    1,162 USD11SEC
    700 shares@ US$1.662.5% of flowCommon stockSEC:0001594062-18-000138:0
    Canonical exit: 11 Oct 2018 (T+90)
  • ▲
    10% OwnerExecutives
    40 USD11SEC
    500 shares@ US$0.080.1% of flowCommon stockSEC:0001594062-18-000135:0
    Canonical exit: 26 Sept 2018 (T+90)
  • ▲
    10% OwnerExecutives
    100 USD11SEC
    1,000 shares@ US$0.100.2% of flowCommon stockSEC:0001594062-18-000132:0
    Canonical exit: 10 Sept 2018 (T+90)
  • ▲
    10% OwnerExecutives
    288 USD11SEC
    3,000 shares@ US$0.0960.6% of flowCommon stockSEC:0001594062-18-000132:1
    Canonical exit: 13 Sept 2018 (T+90)
  • ▲
    10% OwnerExecutives
    600 USD11SEC
    6,000 shares@ US$0.101.3% of flowCommon stockSEC:0001594062-18-000132:2
    Canonical exit: 13 Sept 2018 (T+90)
  • ▲
    10% OwnerExecutives
    355 USD11SEC
    5,000 shares@ US$0.0710.8% of flowCommon stockSEC:0001594062-18-000132:3
    Canonical exit: 13 Sept 2018 (T+90)
  • ▲
    10% OwnerExecutives
    90 USD11SEC
    1,000 shares@ US$0.090.2% of flowCommon stockSEC:0001594062-18-000132:5
    Canonical exit: 23 Sept 2018 (T+90)
  • ▲
    10% OwnerExecutives
    8,668 USD13SEC
    173,363 shares@ US$0.0519.1% of flowCommon stockSEC:0001594062-18-000132:7
    Canonical exit: 26 Sept 2018 (T+90)
  • ▲
    10% OwnerExecutives
    297 USD11SEC
    3,000 shares@ US$0.0990.7% of flowCommon stockSEC:0001594062-18-000132:4
    Canonical exit: 18 Sept 2018 (T+90)
  • ▲
    10% OwnerExecutives
    45 USD11SEC
    500 shares@ US$0.090.1% of flowCommon stockSEC:0001594062-18-000132:6
    Canonical exit: 25 Sept 2018 (T+90)
  • ▲
    10% OwnerExecutives
    200 USD11SEC
    2,000 shares@ US$0.100.4% of flowCommon stockSEC:0001594062-18-000130:0
    Canonical exit: 20 Sept 2018 (T+90)
  • ▲
    10% OwnerExecutives
    6,550 USD12SEC
    65,500 shares@ US$0.1014.4% of flowCommon stockSEC:0001594062-18-000129:0
    Canonical exit: 19 Sept 2018 (T+90)
  • ▲
    10% OwnerExecutives
    99 USD11SEC
    1,000 shares@ US$0.0990.2% of flowCommon stockSEC:0001594062-18-000125:0
    Canonical exit: 17 Sept 2018 (T+90)
  • ▲
    10% OwnerExecutives
    244 USD11SEC
    2,500 shares@ US$0.09750.5% of flowCommon stockSEC:0001594062-18-000125:1
    Canonical exit: 17 Sept 2018 (T+90)
  • ▲
    10% OwnerExecutives
    35 USD5SEC
    500 shares@ US$0.0690.1% of flowCommon stockSEC:0001594062-18-000124:0
    Canonical exit: 4 Jul 2018 (T+90)
  • ▲
    10% OwnerExecutives
    35 USD7SEC
    500 shares@ US$0.0690.1% of flowCommon stockSEC:0001594062-18-000124:1
    Canonical exit: 11 Jul 2018 (T+90)
  • ▲
    10% OwnerExecutives
    16 USD7SEC
    315 shares@ US$0.050.0% of flowCommon stockSEC:0001594062-18-000124:2
    Canonical exit: 11 Jul 2018 (T+90)
  • ▲
    10% OwnerExecutives
    550 USD11SEC
    10,000 shares@ US$0.0551.1% of flowCommon stockSEC:0001594062-18-000124:3
    Canonical exit: 12 Jul 2018 (T+90)
  • ▲
    10% OwnerExecutives
    30 USD11SEC
    500 shares@ US$0.060.1% of flowCommon stockSEC:0001594062-18-000124:4
    Canonical exit: 15 Jul 2018 (T+90)
  • ▲
    10% OwnerExecutives
    900 USD11SEC
    15,000 shares@ US$0.061.9% of flowCommon stockSEC:0001594062-18-000124:5
    Canonical exit: 19 Jul 2018 (T+90)
  • ▲
    10% OwnerExecutives
    1,200 USD11SEC
    20,000 shares@ US$0.062.5% of flowCommon stockSEC:0001594062-18-000124:6
    Canonical exit: 23 Jul 2018 (T+90)
  • ▲
    10% OwnerExecutives
    65 USD11SEC
    1,000 shares@ US$0.0650.1% of flowCommon stockSEC:0001594062-18-000124:8
    Canonical exit: 8 Aug 2018 (T+90)
  • ▲
    10% OwnerExecutives
    75 USD11SEC
    1,000 shares@ US$0.0750.2% of flowCommon stockSEC:0001594062-18-000124:9
    Canonical exit: 12 Aug 2018 (T+90)
  • ▲
    10% OwnerExecutives
    2,211 USD11SEC
    30,000 shares@ US$0.07374.8% of flowCommon stockSEC:0001594062-18-000124:11
    Canonical exit: 13 Aug 2018 (T+90)

25 of 66 declarations

About HCi Viocare

HCi Viocare is a company listed on the XNAS market, specializing in the development of innovative health solutions. It focuses on improving patient care through technology.